C18ORF55 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.180360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.788600E-01
Normal-vs-Stage2
6.672100E-02
Normal-vs-Stage3
9.590100E-02
Normal-vs-Stage4
3.148200E-01
Stage1-vs-Stage2
1.892420E-01
Stage1-vs-Stage3
3.357400E-01
Stage1-vs-Stage4
6.149200E-01
Stage2-vs-Stage3
5.461600E-01
Stage2-vs-Stage4
8.908200E-01
Stage3-vs-Stage4
6.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.339640E-01
Normal-vs-AfricanAmerican
3.599900E-02
Normal-vs-Asian
2.312000E-02
Caucasian-vs-AfricanAmerican
5.628600E-01
Caucasian-vs-Asian
4.844400E-02
AfricanAmerican-vs-Asian
9.401800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.933700E-02
Normal-vs-Female
1.739190E-01
Male-vs-Female
6.192100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.165900E-02
Normal-vs-Age(41-60Yrs)
3.223400E-01
Normal-vs-Age(61-80Yrs)
6.096200E-02
Normal-vs-Age(81-100Yrs)
1.698830E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.461000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.142400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.620400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.760700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.810600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.284700E-03
Normal-vs-Daily Drinker
9.710200E-02
Normal-vs-Weekly Drinker
5.756200E-02
Normal-vs-Occasional Drinker
2.731200E-01
Normal-vs-Social Drinker
5.316600E-01
Non Drinker-vs-Daily Drinker
5.620000E-01
Non Drinker-vs-Weekly Drinker
5.860400E-01
Non Drinker-vs-Occasional Drinker
3.473500E-02
Non Drinker-vs-Social Drinker
4.367800E-02
Daily Drinker-vs-Weekly Drinker
9.844400E-01
Daily Drinker-vs-Occasional Drinker
2.235600E-01
Daily Drinker-vs-Social Drinker
1.186770E-01
Weekly Drinker-vs-Occasional Drinker
2.326800E-01
Weekly Drinker-vs-Social Drinker
1.384350E-01
Occasional Drinker-vs-Social Drinker
6.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.427800E-01
Normal-vs-Grade 2
7.259800E-01
Normal-vs-Grade 3
7.228400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.332400E-01
Grade 1-vs-Grade 3
2.623600E-01
Grade 1-vs-Grade 4
3.427800E-01
Grade 2-vs-Grade 3
9.501000E-01
Grade 2-vs-Grade 4
7.259800E-01
Grade 3-vs-Grade 4
7.228400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.698200E-02
Normal-vs-NonDiabetic
1.053200E-01
Diabetic-vs-NonDiabetic
1.562980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.423660E-02
Normal-vs-NoPancreatitis
7.663800E-02
Pancreatitis-vs-NoPancreatitis
2.028200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.309200E-01
Normal-vs-N1
7.950100E-02
N0-vs-N1
7.219800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.767700E-02
Normal-vs-TP53-NonMutant
4.477000E-01
TP53-Mutant-vs-TP53-NonMutant
5.350900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
